and not good. Talks of weakened demand in April and forward bookings so indicating profit forecast to be "at lower end of $80-110m range" previously provided.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025